Abcellera Biologics Inc.

This early-stage study tests a new drug, ABCL635, given as a shot under the skin. It first checks safety in healthy men and women, then looks at whether it can reduce the number and severity of hot flashes in postmenopausal women with moderate-to-severe symptoms. About 136 people…

This early-stage study is testing a new drug called ABCL575 for the first time in people. It involves 40 healthy adults who will receive either a single dose of ABCL575 or a placebo. The main goal is to check if the drug is safe and how the body handles it. No treatment benefit i…